JA

Profile

Research

Social

Other

Sanada Fumihiro

眞田 文博

Graduate School of Medicine, Endowed Chair Associate Professor

Research Areas

  • Life sciences, Tumor diagnostics and therapeutics
  • Life sciences, Cardiology

Professional Memberships

  • アメリカ心臓病学会
  • 日本内科学会
  • 日本循環器病学会

Papers

  • Blocking Periostin Prevented Development of Inflammation in Rhabdomyolysis-Induced Acute Kidney Injury Mice Model, Jun Muratsu,Fumihiro Sanada,Nobutaka Koibuchi,Kana Shibata,Naruto Katsuragi,Shoji Ikebe,Yasuo Tsunetoshi,Hiromi Rakugi,Ryuichi Morishita,Yoshiaki Taniyama, Cells, MDPI AG, Vol. 11, No. 21, p. 3388-3388, 2022/10/27
  • Periostin Exon-21 Antibody Neutralization of Triple-Negative Breast Cancer Cell-Derived Periostin Regulates Tumor-Associated Macrophage Polarization and Angiogenesis, Tatsuya Fujikawa,Fumihiro Sanada,Yoshiaki Taniyama,Kana Shibata,Naruto Katsuragi,Nobutaka Koibuchi,Kaori Akazawa,Yuko Kanemoto,Hidehito Kuroyanagi,Kenzo Shimazu,Hiromi Rakugi,Ryuichi Morishita, Cancers, MDPI AG, Vol. 13, No. 20, p. 5072-5072, 2021/10/11
  • Periostin Short Fragment with Exon 17 via Aberrant Alternative Splicing Is Required for Breast Cancer Growth and Metastasis, Yuka Ikeda-Iwabu,Yoshiaki Taniyama,Naruto Katsuragi,Fumihiro Sanada,Nobutaka Koibuchi,Kana Shibata,Kenzo Shimazu,Hiromi Rakugi,Ryuichi Morishita, Cells, MDPI AG, Vol. 10, No. 4, p. 892-892, 2021/04/14
  • Progress of Gene Therapy in Cardiovascular Disease., Munehisa Shimamura,Hironori Nakagami,Fumihiro Sanada,Ryuichi Morishita, Hypertension (Dallas, Tex. : 1979), Vol. 76, No. 4, p. 1038-1044, 2020/10
  • Therapeutic Angiogenesis Using HGF Plasmid, Fumihiro Sanada,Tatsuya Fujikawa,Kana Shibata,Yoshiaki Taniyama,Hiromi Rakugi,Ryuichi Morishita, Annals of Vascular Diseases, The Editorial Committee of Annals of Vascular Diseases, Vol. 13, No. 2, p. 109-115, 2020/06/25
  • Gene-Therapeutic Strategies Targeting Angiogenesis in Peripheral Artery Disease., Fumihiro Sanada,Yoshiaki Taniyama,Jun Muratsu,Rei Otsu,Hideo Shimizu,Hiromi Rakugi,Ryuichi Morishita, Medicines (Basel, Switzerland), Vol. 5, No. 2, 2018/03/30
  • Periostin blockade overcomes chemoresistance via restricting the expansion of mesench, Nakazawa Y,Taniyama Y,Sanada F,Morishita R,Nakamori S,Morimoto K,Yeung KT,Yang J, Sci Rep., 2018/03
  • Mutagenicity of titanium grinding powder corroded with hydrofluoric acid using umu-test, Hideo Shimizu,Fumihiro Sanada,Yoshiaki Taniyama,Ryuichi Morishita, Nano Biomedicine, National Institute of Informatics, Vol. 9, No. 2, p. 89-93, 2018
  • IGF Binding Protein-5 Induces Cell Senescence., Fumihiro Sanada,Yoshiaki Taniyama,Jun Muratsu,Rei Otsu,Hideo Shimizu,Hiromi Rakugi,Ryuichi Morishita, Frontiers in endocrinology, Vol. 9, p. 53-53, 2018
  • Source of Chronic Inflammation in Aging., Fumihiro Sanada,Yoshiaki Taniyama,Jun Muratsu,Rei Otsu,Hideo Shimizu,Hiromi Rakugi,Ryuichi Morishita, Frontiers in cardiovascular medicine, Vol. 5, p. 12-12, 2018
  • Local Production of Activated Factor X in Atherosclerotic Plaque Induced Vascular Smooth Muscle Cell Senescence, Fumihiro Sanada,Jun Muratsu,Rei Otsu,Hideo Shimizu,Nobutaka Koibuchi,Kazutaka Uchida,Yoshiaki Taniyama,Shinichi Yoshimura,Hiromi Rakugi,Ryuichi Morishita, SCIENTIFIC REPORTS, NATURE PUBLISHING GROUP, Vol. 7, 2017/12
  • Single-cell analysis of the fate of c-kit-positive bone marrow cells., Czarna A,Sanada F,Matsuda A,Kim J,Signore S,Pereira JD,Sorrentino A,Kannappan R,Cannatà A,Hosoda T,Rota M,Crea F,Anversa P,Leri A, NPJ Regen Med., 2017/10
  • Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice, Jun Muratsu,Masaaki Iwabayashi,Fumihiro Sanada,Yoshiaki Taniyama,Rei Otsu,Hiromi Rakugi,Ryuichi Morishita, SCIENTIFIC REPORTS, NATURE PUBLISHING GROUP, Vol. 7, No. 1, 2017/03
  • p53 Modulates the Fate of Cardiac Progenitor Cells Ex Vivo and in the Diabetic Heart In Vivo, Ramaswamy Kannappan,Alex Matsuda,Joao Ferreira-Martins,Eric Zhang,Giorgia Palano,Anna Czarna,Mauricio Castro Cabral-Da-Silva,Adriana Bastos-Carvalho,Fumihiro Sanada,Noriko Ide,Marcello Rota,Maria A. Blasco,Manuel Serrano,Piero Anversa,Annarosa Leri, EBIOMEDICINE, ELSEVIER SCIENCE BV, Vol. 16, p. 224-237, 2017/02
  • Activated Factor X Induces Endothelial Cell Senescence Through IGFBP-5, Fumihiro Sanada,Yoshiaki Taniyama,Jun Muratsu,Rei Otsu,Masaaki Iwabayashi,Miguel Carracedo,Hiromi Rakugi,Ryuichi Morishita, SCIENTIFIC REPORTS, NATURE PUBLISHING GROUP, Vol. 6, 2016/10
  • Induction of angiogenesis by a type III phosphodiesterase inhibitor, cilostazol, through activation of peroxisome proliferator-activated receptor-γ and cAMP pathways in vascular cells, Fumihiro Sanada,Yasuhiro Kanbara,Yoshiaki Taniyama,Rei Otsu,Miguel Carracedo,Yuka Ikeda-Iwabu,Jun Muratsu,Ken Sugimoto,Koichi Yamamoto,Hiromi Rakugi,Ryuichi Morishita, Arteriosclerosis, Thrombosis, and Vascular Biology, Lippincott Williams and Wilkins, Vol. 36, No. 3, p. 545-552, 2016/03/01
  • Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Thr, Sanada F,Kanbara Y,Taniyama Y,Otsu R,Carracedo M,Ikeda-Iwabu Y,Muratsu J,Sugimoto K,Yamamoto K,Rakugi H,Morishita R, Arterioscler Thromb Vasc Biol., 2016/03
  • Selective Blockade of Periostin Exon 17 Preserves Cardiac Performance in Acute Myocardial Infarction, Yoshiaki Taniyama,Naruto Katsuragi,Fumihiro Sanada,Junya Azuma,Kazuma Iekushi,Nobutaka Koibuchi,Keita Okayama,Yuka Ikeda-Iwabu,Jun Muratsu,Rei Otsu,Hiromi Rakugi,Ryuichi Morishita, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 67, No. 2, p. 356-361, 2016/02
  • Gene therapy in peripheral artery disease, Fumihiro Sanada,Yoshiaki Taniyama,Yasuhiro Kanbara,Rei Otsu,Yuka Ikeda-Iwabu,Miguel Carracedo,Hiromi Rakugi,Ryuichi Morishita, EXPERT OPINION ON BIOLOGICAL THERAPY, TAYLOR & FRANCIS LTD, Vol. 15, No. 3, p. 381-390, 2015/03
  • Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent., Fumihiro Sanada,Yoshiaki Taniyama,Junya Azuma,Ikeda-Iwabe Yuka,Yasuhiro Kanbara,Masaaki Iwabayashi,Hiromi Rakugi,Ryuichi Morishita, Immunology, endocrine & metabolic agents in medicinal chemistry, Vol. 14, No. 1, p. 32-39, 2014/04
  • Endothelial progenitor cells in clinical settings, Fumihiro Sanada,Yoshiaki Taniyama,Junya Azuma,Ikeda-Iwabe Yuka,Masaaki Iwabayashi,Hiromi Rakugi,Ryuichi Morishita, Journal of Stem Cells, Nova Science Publishers, Inc., Vol. 9, No. 2, p. 117-125, 2014
  • c-Kit-Positive Cardiac Stem Cells Nested in Hypoxic Niches Are Activated by Stem Cell Factor Reversing the Aging Myopathy, Fumihiro Sanada,Junghyun Kim,Anna Czarna,Noel Yan-Ki Chan,Sergio Signore,Barbara Ogorek,Kazuya Isobe,Ewa Wybieralska,Giulia Borghetti,Ada Pesapane,Andrea Sorrentino,Emily Mangano,Donato Cappetta,Chiara Mangiaracina,Mario Ricciardi,Maria Cimini,Emeka Ifedigbo,Mark A. Perrella,Polina Goichberg,Augustine M. Choi,Jan Kajstura,Toru Hosoda,Marcello Rota,Piero Anversa,Annarosa Leri, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 114, No. 1, p. 41-55, 2014/01
  • Inositol 1, 4, 5-Trisphosphate Receptors and Human Left Ventricular Myocytes, Sergio Signore,Andrea Sorrentino,Joao Ferreira-Martins,Ramaswamy Kannappan,Mehrdad Shafaie,Fabio Del Ben,Kazuya Isobe,Christian Arranto,Ewa Wybieralska,Andrew Webster,Fumihiro Sanada,Barbara Ogorek,Hanqiao Zheng,Xiaoxia Liu,Federica del Monte,David A. D'Alessandro,Oriyanhan Wunimenghe,Robert E. Michler,Toru Hosoda,Polina Goichberg,Annarosa Leri,Jan Kajstura,Piero Anversa,Marcello Rota, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 128, No. 12, p. 1286-1297, 2013/09
  • マウスにおける肝細胞増殖因子による肥満と糖代謝の恒常性障害からの保護(Protection from obesity and impaired glucose homeostasis by Hepatocyte growth factor in mice), 岩林 正明,谷山 義明,東 純哉,家串 和真,眞田 文博,清水 一賢,楽木 宏実,森下 竜一, 日本抗加齢医学会総会プログラム・抄録集, (一社)日本抗加齢医学会, Vol. 13回, p. 199-199, 2013/06
  • Dissecting the molecular relationship among various cardiogenic progenitor cells., Dey D,Han L,Bauer M,Sanada F,Oikonomopoulos A,Hosoda T,Unno K,De Almeida P,Leri A,Wu JC, Circ Res., 2013/03
  • Novel mechanism of hepatocyte growth factor against prevention of inflammation and oxidative stress, Shimizu Kazutaka,Taniyama Yoshiaki,Sanada Fumihiro,Iwabayashi Masaaki,Azuma Junya,Iekushi Kazuma,Katsuragi Naruto,Otsu Rei,Shibata Kana,Ishikawa Yutaro,Rakugi Hiromi,Morishita Ryuichi, Inflammation and Regeneration, The Japanese Society of Inflammation and Regeneration, Vol. 33, No. 3, p. 136-142, 2013
  • Evaluation of pregabalin therapy in peripheral neuropathy, Kazutaka Shimizu,Yoshiaki Taniyama,Junya Azuma,Fumihiro Sanada,Masaaki Iwabayashi,Yuki Yamane,Hiroko Yamasaki,Atsuko Akasaki,Ryuichi Morishita, Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Vol. 13, No. 2, p. 132-138, 2013
  • Role of serotonin in angiogenesis in diabetes, Masaaki Iwabayashi,Yoshiaki Taniyama,Junya Azuma,Fumihiro Sanada,Kazuma Iekushi,Hiromi Rakugi,Ryuichi Morishita, Biochemical Basis and Therapeutic Implications of Angiogenesis, Springer New York, p. 225-238, 2013/01/01
  • Hepatocyte Growth Factor Inhibits Lipopolysaccharide-Induced Oxidative Stress via Epithelial Growth Factor Receptor Degradation, Kazutaka Shimizu,Yoshiaki Taniyama,Fumihiro Sanada,Junya Azuma,Masaaki Iwabayashi,Kazuma Iekushi,Hiromi Rakugi,Ryuichi Morishita, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 32, No. 11, p. 2687-+, 2012/11
  • Response to hepatocyte growth factor and cardiomyopathy in dialysis patients, Ryuichi Morishita,Keita Okayama,Junya Azuma,Norio Dosaka,Kazuma Iekushi,Fumihiro Sanada,Hiroshi Kusunoki,Masaaki Iwabayashi,Hiromi Rakugi,Yoshiaki Taniyama, Hypertension, Vol. 60, No. 3, p. e25-e26, 2012/09
  • Inhibition of Lp(a)-induced functional impairment of endothelial cells and endothelial progenitor cells by hepatocyte growth factor, Masaaki Iwabayashi,Yoshiaki Taniyama,Fumihiro Sanada,Junya Azuma,Kazuma Iekushi,Keita Okayama,Amarnath Chatterjee,Hiromi Rakugi,Ryuichi Morishita, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 423, No. 1, p. 79-84, 2012/06
  • Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition., Keita Okayama,Junya Azuma,Norio Dosaka,Kazuma Iekushi,Fumihiro Sanada,Hiroshi Kusunoki,Masaaki Iwabayashi,Hiromi Rakugi,Yoshiaki Taniyama,Ryuichi Morishita, Hypertension (Dallas, Tex. : 1979), Vol. 59, No. 5, p. 958-65, 2012/05
  • Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition., Okayama K,Azuma J,Dosaka N,Iekushi K,Sanada F,Kusunoki H,Iwabayashi M,Rakugi H,Taniyama Y,Morishita R, Hypertension, 2012/03
  • Role of serotonin in angiogenesis: Induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice, Masaaki Iwabayashi,Yoshiaki Taniyama,Fumihiro Sanada,Junya Azuma,Kazuma Iekushi,Hiroshi Kusunoki,Amarnath Chatterjee,Keita Okayama,Hiromi Rakugi,Ryuichi Morishita, ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, Vol. 220, No. 2, p. 337-342, 2012/02
  • Telmisartan Exerts Renoprotective Actions via Peroxisome Proliferator-Activated Receptor-gamma/Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1 Receptor Blockade, Hiroshi Kusunoki,Yoshiaki Taniyama,Junya Azuma,Kazuma Iekushi,Fumihiro Sanada,Rei Otsu,Masaaki Iwabayashi,Keita Okayama,Hiromi Rakugi,Ryuichi Morishita, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 59, No. 2, p. 308-+, 2012/02
  • Comparison between two calcium antagonists: Blood pressure reduction and renal effects in hypertensive patients with type 2 diabetes, Toyohiko Yokoi,Junya Azuma,Yukiyoshi Nakade,Fumihiro Sanada,Kazuma Iekushi,Masamichi Yoshika,Midori Masuda,Yutaka Komiyama,Yoshiaki Taniyama,Hiroya Masaki,Ryuichi Morishita,Hakuo Takahashi, Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Bentham Science Publishers B.V., Vol. 12, No. 2, p. 152-159, 2012
  • The HGF/c-met receptor system under pathological conditions, Yoshiaki Taniyama,Junya Azuma,Kazuma Iekushi,Fumihiro Sanada,Masaaki Iwabayashi,Hiroshi Kusunoki,Keita Okayama,Rei Otsu,Hiromi Rakugi,Ryuichi Morishita, Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Bentham Science Publishers B.V., Vol. 12, No. 2, p. 122-129, 2012
  • HGP/c-Met系は、LPS誘発Vcam-1発現とEGP受容体のユビキチン化による酸化ストレスを抑制する(HGP/c-Met sytem Inhibits LPS-Induced Vcam-1 expression and Oxidative Stress via EGP Receptor ubiquitination), 清水 一賢,谷山 義明,岩林 正明,眞田 文博,東 純哉,久徳 真梨子,楠 博,岡山 慶太,森下 竜一, Anti-aging Science, (株)メディカルレビュー社, Vol. 3, No. Suppl.1, p. 326-326, 2011/11
  • イルベサルタンの抗メタボリックシンドローム作用と肝細胞増殖因子との関連, アマルナス・チャタジー,谷山 義明,楠 博,東 純哉,家串 和真,眞田 文博,大津 礼,岩林 正明,岡山 慶太,楽木 宏実,森下 竜一, Anti-aging Science, (株)メディカルレビュー社, Vol. 3, No. Suppl.1, p. 322-322, 2011/11
  • 肝細胞増殖因子(HGF)の抗炎症効果によるメタボリックシンドローム病態への改善, 楠 博,谷山 義明,東 純哉,大津 礼,岩林 正明,家串 和真,眞田 文博,アマルナス・チャタジー,岡山 慶太,楽木 宏実,森下 竜一, Anti-aging Science, (株)メディカルレビュー社, Vol. 3, No. Suppl.1, p. 322-322, 2011/11
  • イルベサルタンの臓器保護作用と肝細胞増殖因子(HGF) アルドステロン負荷モデルでの検討, 大津 礼,谷山 義明,楠 博,東 純哉,家串 和真,眞田 文博,アマルナス・チャタジー,岩林 正明,岡山 慶太,楽木 宏実,森下 竜一, Anti-aging Science, (株)メディカルレビュー社, Vol. 3, No. Suppl.1, p. 328-328, 2011/11
  • テルミサルタンのPPARγ/HGF経路を介した腎保護効果の検討, 楠 博,谷山 義明,大津 礼,岩林 正明,東 純哉,家串 和真,眞田 文博,アマルナス・チャタジー,岡山 慶太,楽木 宏実,森下 竜一, Anti-aging Science, (株)メディカルレビュー社, Vol. 3, No. Suppl.1, p. 330-330, 2011/11
  • 肝細胞増殖因子(HGF)のメタボリックシンドローム(MetS)病態の改善効果, 楠 博,谷山 義明,東 純哉,岩林 正明,アマルナット・チャッタッジー,大津 礼,家串 和真,真田 文博,岡山 慶太,楽木 宏実,森下 竜一, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 34回, p. 419-419, 2011/10
  • Critical Roles of Cold Shock Domain Protein A as an Endogenous Angiogenesis Inhibitor in Skeletal Muscle, Yukihiro Saito,Hironori Nakagami,Nobuyoshi Azuma,Satoshi Hirata,Fumihiro Sanada,Yoshiaki Taniyama,Ryuichi Morishita,Yasufumi Kaneda,Tadahiro Sasajima, ANTIOXIDANTS & REDOX SIGNALING, MARY ANN LIEBERT INC, Vol. 15, No. 8, p. 2109-2120, 2011/10
  • 肝細胞増殖因子(HGF)のメタボリックシンドローム(MetS)病態の改善効果, 楠 博,谷山 義明,東 純哉,真田 文博,アマルナット・チャッタッジー,大津 礼,岩林 正明,岡山 慶太,楽木 宏実,森下 竜一, 日本内分泌学会雑誌, (一社)日本内分泌学会, Vol. 87, No. 2, p. 775-775, 2011/09
  • Role of periostin in cancer progression and metastasis: Inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model, Mariko Kyutoku,Yoshiaki Taniyama,Naruto Katsuragi,Hideo Shimizu,Yasuo Kunugza,Kazuma Iekushi,Nobutaka Koibuchi,Fumthiro Sanada,Yoshihiro Oshita,Ryuichi Morishita, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, SPANDIDOS PUBL LTD, Vol. 28, No. 2, p. 181-186, 2011/08
  • Hepatocyte Growth Factor Attenuates Transforming Growth Factor-beta-Angiotensin II Crosstalk Through Inhibition of the PTEN/Akt Pathway, Kazuma Iekushi,Yoshiaki Taniyama,Hiroshi Kusunoki,Junya Azuma,Fumihiro Sanada,Keita Okayama,Nobutaka Koibuchi,Masaaki Iwabayashi,Hiromi Rakugi,Ryuichi Morishita, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 58, No. 2, p. 190-U136, 2011/08
  • HGF(肝細胞増殖因子)はARBの腎保護作用のエフェクター分子である, 楠 博,谷山 義明,家串 和真,真田 文博,東 純哉,岡山 慶太,岩林 正明,楽木 宏実,森下 竜一, 日本腎臓学会誌, (一社)日本腎臓学会, Vol. 53, No. 3, p. 433-433, 2011/05
  • EGF受容体の崩壊によって、HGFはLPS-誘導酸化ストレスと炎症を阻害する(HGF Inhibits LPS-Induced Oxidative Stress and Inflammation via EGF Receptor Degradation), 清水 一賢,谷山 義明,眞田 文博,岩林 正明,楠 博,岡山 慶太,森下 竜一, 日本抗加齢医学会総会プログラム・抄録集, (一社)日本抗加齢医学会, Vol. 11回, p. 337-337, 2011/04
  • ValsartanはAngiotensin II受容体非依存的にintegrin αVβ3を制御しLp(a)誘発性動脈硬化病変を抑制する, 岩林 正明,谷山 義明,真田 文博,東 純哉,家串 和真,岡山 慶太,楠 博,清水 一賢,Chatterjee Amarnath,楽木 宏美,森下 竜一, 日本抗加齢医学会総会プログラム・抄録集, (一社)日本抗加齢医学会, Vol. 11回, p. 324-324, 2011/04
  • Hepatocyte growth factor attenuates renal fibrosis through TGF-beta 1 suppression by apoptosis of myofibroblasts, Kazuma Iekushi,Yoshiaki Taniyama,Junya Azuma,Fumihiro Sanada,Hiroshi Kusunoki,Toyohiko Yokoi,Nobutaka Koibuchi,Keita Okayama,Hiromi Rakugi,Ryuichi Morishita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 28, No. 12, p. 2454-2461, 2010/12
  • HGF(肝細胞増殖因子)はPPARγアゴニスト作用を持つARBの腎保護作用のエフェクター分子として発現する, 楠 博,谷山 義明,家串 和真,眞田 文博,岡山 慶太,東 純哉,楽木 宏実,森下 竜一, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 33回, p. 348-348, 2010/10
  • HGF(肝細胞増殖因子)はTGF-b1とアンジオテンシン2のクロストークをPTEN/Akt経路を介し、アンジオテンシン1型受容体(AT1R)の発現を抑制することで抑える, 楠 博,谷山 義明,家串 和真,眞田 文博,東 純哉,岡山 慶太,楽木 宏実,森下 竜一, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 33回, p. 348-348, 2010/10
  • 【透析患者の下肢切断をなくすために 末梢動脈疾患(PAD)の診断と治療】PADへの遺伝子治療, 谷山 義明,眞田 文博,岡山 慶太,楠 博,岩林 正明,森下 竜一, 臨床透析, (株)日本メディカルセンター, Vol. 26, No. 7, p. 995-1005, 2010/06
  • 肝細胞増殖因子(HGF)はPTEN/Akt経路を介し、腎臓線維化を抑制する, 楠 博,谷山 義明,家串 和真,真田 文博,東 純哉,尾崎 和成,堂阪 宜雄,岡山 慶太,楽木 宏実,森下 竜一, 日本抗加齢医学会総会プログラム・抄録集, (一社)日本抗加齢医学会, Vol. 10回, p. 196-196, 2010/05
  • 【高血圧(第4版) 日本における最新の研究動向】基礎編 循環生理活性物質の最新知見 血管作動性物質 生合成、分泌、生理作用 肝細胞増殖因子(HGF)、血管内皮細胞増殖因子(VEGF), 真田 文博,谷山 義明,家串 和真,森下 竜一, 日本臨床, (株)日本臨床社, Vol. 67, No. 増刊6 高血圧(上), p. 283-287, 2009/10
  • HGFは筋線維芽細胞のアノイキスを誘発することで、腎臓における抗線維化作用を発揮する, 楠 博,谷山 義明,家串 和真,東 純哉,堂阪 宜雄,真田 文博,鯉渕 信孝,楽木 宏実,森下 竜一, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 32回, p. 274-274, 2009/10
  • Negative Action of Hepatocyte Growth Factor/c-Met System on Angiotensin II Signaling via Ligand-Dependent Epithelial Growth Factor Receptor Degradation Mechanism in Vascular Smooth Muscle Cells, Fumihiro Sanada,Yoshiaki Taniyama,Kazuma Iekushi,Junya Azuma,Keita Okayama,Hiroshi Kusunoki,Nobutaka Koibuchi,Takefumi Doi,Yoshifusa Aizawa,Ryuichi Morishita, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 105, No. 7, p. 667-U53, 2009/09
  • EGF receptorシグナルのSHIP2 translocationを介したスイッチングsystemの解明, 岡山 慶太,谷山 義明,眞田 文博,楠 博,森下 竜一, 日本内分泌学会雑誌, (一社)日本内分泌学会, Vol. 85, No. 2, p. 723-723, 2009/09
  • Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells., Sanada F,Taniyama Y,Iekushi K,Azuma J,Okayama K,Kusunoki H,Koibuchi N,Doi T,Aizawa Y,Morishita R, Circ Res., 2009/08
  • 【ACE阻害薬とARB どう使い分けるか】診る 循環系RASと組織RAS, 谷山 義明,家串 和真,眞田 文博,武田 朱公,森下 竜一, Heart View, (株)メジカルビュー社, Vol. 13, No. 2, p. 132-139, 2009/02
  • EGFR degradationを介した肝細胞増殖因子(HGF)/c-Metシステムの抗老化、抗動脈硬化メカニズムの解明, 眞田 文博,谷山 義明,家串 和真,森下 竜一, 血管, 日本心脈管作動物質学会, Vol. 32, No. 1, p. 15-15, 2009/01
  • Hepatocyte Growth Factor, but not Vascular Endothelial Growth Factor, Attenuates Angiotensin II-Induced Endothelial Progenitor Cell Senescence, Fumihiro Sanada,Yoshiaki Taniyama,Junya Azuma,Kazuma Iekushi,Norio Dosaka,Toyohiko Yokoi,Nobutaka Koibuchi,Hiroshi Kusunoki,Yoshifusa Aizawa,Ryuichi Morishita, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 53, No. 1, p. 77-U137, 2009/01
  • 肝細胞増殖因子(HGF)による腎臓における筋線維芽細胞のアノイキスを介した直接的なTGF-β1抑制効果の解明, 家串 和真,谷山 義明,東 純哉,真田 文博,堂阪 宣雄,楠 博,横井 豊彦,樂木 宏実,森下 竜一, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 31回, p. 304-304, 2008/10
  • ウルソデオキシコール酸による血管内皮由来Plasminogen Activator Inhibitor-1(PAI-1)の抑制作用, 横井 豊彦,和田 良春,真田 文博,家串 和真,吉賀 正亨,桝田 緑,小宮山 豊,谷山 義明,正木 浩哉,越山 裕行,高橋 伯夫, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 31回, p. 344-344, 2008/10
  • 【閉塞性動脈硬化症 治療戦略の変化と進歩】先進医療 末梢動脈閉塞性疾患に対する再生医療 遺伝子治療, 谷山 義明,東 純哉,家串 和真,眞田 文博,堂阪 宜雄,楠 博,清水 一賢,森下 竜一, カレントテラピー, (株)ライフメディコム, Vol. 26, No. 9, p. 801-805, 2008/09
  • 血管内皮成長因子ではなく肝細胞成長因子はEPCのアンジオテンシンII誘発性老化を減弱化させる(Hepatocyte Growth Factor, but not Vascular Endothelial Growth Factor, Attenuated Ang II-induced Senescence in EPC), 谷山 義明,眞田 文博,家串 和真,堂阪 宜雄,森下 竜一, 日本抗加齢医学会総会プログラム・抄録集, (一社)日本抗加齢医学会, Vol. 8回, p. 203-203, 2008/06
  • 肝細胞増殖因子はrac1の活性化を抑制することによりアンジオテンシンIIによる血管内皮細胞の老化を抑制する, 眞田 文博,谷山 義明,家串 和真,堂坂 宣夫,森下 竜一, 脈管学, (一社)日本脈管学会, Vol. 47, No. Suppl., p. S104-S104, 2007/09
  • 肝細胞増殖因子(HGF)と血管内皮細胞増殖因子(VEGF)による血管内皮前駆細胞(EPC)への抗酸化・抗老化作用の比較 GTP結合rac1への効果の相違, 眞田 文博,谷山 義明,家串 和真,堂坂 宜雄,相澤 義房,森下 竜一, 日本内分泌学会雑誌, (一社)日本内分泌学会, Vol. 83, No. 2, p. 590-590, 2007/09
  • Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin, Kazuma Iekushi,Yoshiaki Taniyama,Junya Azuma,Naruto Katsuragi,Norio Dosaka,Fumihiro Sanada,Nobutaka Koibuchi,Kaori Nagao,Toshio Ogihara,Ryuichi Morishita, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 49, No. 6, p. 1409-1414, 2007/06
  • Novel mechanisms of angiotensin receptor blocker, valsartan, treatment of AMI through inhibition of anti-adhesion molecule, periostin, K. Iekushi,Y. Taniyama,J. Azuma,N. Dosaka,F. Sanada,T. Ogihara,R. Morishita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 25, p. S181-S181, 2007/06
  • Serum Endostatin in the Coronary Circulation of Patients With Coronary Heart Disease and Its Relation to Coronary Collateral Formation, Wataru Mitsuma,Makoto Kodama,Haruo Hanawa,Masahiro Ito,Mahmoud M. Ramadan,Satoru Hirono,Hiroaki Obata,Shinsuke Okada,Fumihiro Sanada,Takao Yanagawa,Takeshi Kashimura,Koichi Fuse,Naohito Tanabe,Yoshifusa Aizawa, American Journal of Cardiology, Vol. 99, No. 4, p. 494-498, 2007/02/15

Misc.

  • 病的ペリオスチンバリアントをターゲットにした乳がん治療法の開発—Development of new therapeutics against chemo-resistant breast cancer—研究者の最新動向, 眞田 文博,谷山 義明,藤川 龍弥,柴田 佳那,楽木 宏実,森下 竜一, Precision medicine = プレシジョンメディシン / 「Precision medicine」編集委員会 編, Vol. 5, No. 2, p. 184-187, 2022/02
  • Prometheus Bio社 イムノクロマト法を用いたCOVID-19診断精度の検討, 藤川龍弥,眞田文博,中神啓徳,森下竜一, Pharma Medica, Vol. 39, No. 7, 2021
  • 循環器疾患とCOVID-19—Cardiovascular disease and COVID-19, 眞田 文博,藤川 龍弥,楽木 宏実,森下 竜一, 循環器内科 = Cardioangiology / 循環器内科編集委員会 編, 科学評論社, Vol. 88, No. 5, p. 549-552, 2020/11
  • 治療抵抗性トリプルネガティブ乳がん治療法の開発—Development of new therapeutics against chemo-resistant breast cancer—研究者の最新動向, 眞田 文博,谷山 義明,藤川 龍弥,柴田 佳那,楽木 宏実,森下 竜一, Precision medicine = プレシジョンメディシン / 「Precision medicine」編集委員会 編, 北隆館, Vol. 3, No. 13, p. 1259-1262, 2020/11
  • 核酸医薬を用いた高血圧治療, 眞田 文博,森下 竜 一, 日本臨牀, Vol. 78, No. 2, p. 140-144, 2020/07
  • 化学療法抵抗性トリプルネガティブ乳がん新規治療法の開発, 眞田文博,谷山義明,藤川龍弥,柴田佳那,森下竜一, Precision Medicine, Vol. 45, No. 3, 2020/04
  • periostinのスプライシング・バリアントを標的とした画期的乳癌治療法の開発, 柴田 佳那,谷山 義明,眞田 文博,村津 淳,大津 礼,藤川 龍弥,楽木 宏実,森下 竜一, Anti-aging Science, (株)メディカルレビュー社, Vol. 10, No. 1, p. 72-72, 2018/12
  • 食塩誘導性腎障害モデルマウスにおけるLCZ696の繊維化抑制を主とした薬効評価, 大津 礼,谷山 義明,眞田 文博,村津 淳,楽木 宏実,森下 竜一, 日本抗加齢医学会総会プログラム・抄録集, (一社)日本抗加齢医学会, Vol. 18回, p. 243-243, 2018/05
  • Periostin exon17の選択的阻害による腎線維化への影響, 村津 淳,眞田 文博,谷山 義明,大津 礼,楽木 宏実,森下 竜一, 日本内分泌学会雑誌, (一社)日本内分泌学会, Vol. 93, No. 4, p. 1385-1385, 2017/12
  • 細胞外マトリックスPeriostinとマスト細胞の分化機能獲得との関連, 村津 淳,眞田 文博,谷山 義明,大津 礼,楽木 宏実,森下 竜一, 日本内分泌学会雑誌, (一社)日本内分泌学会, Vol. 93, No. 4, p. 1389-1389, 2017/12
  • 血中肝細胞増殖因子(hepatocyte growth factor:HGF)の肥満抑制効果とインスリン抵抗性との関連, 村津 淳,岩林 正明,眞田 文博,谷山 義明,大津 礼,楽木 宏実,森下 竜一, 日本内分泌学会雑誌, (一社)日本内分泌学会, Vol. 93, No. 4, p. 1387-1387, 2017/12
  • 食塩誘導性腎障害AT1RKOマウスにおけるLCZ696の薬効評価 腎臓線維化と糸球体保護作用を有する, 大津 礼,谷山 義明,眞田 文博,村津 淳,楽木 宏実,森下 竜一, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 40回, p. 368-368, 2017/10
  • 肝細胞増殖因子(hepatocyte growth factor:HGF)の肥満とインスリン抵抗性に対する代償機構について, 村津 淳,岩林 正明,眞田 文博,谷山 義明,大津 礼,柴田 佳那,ブルーレイ・メイ,加和子,楽木 宏実,森下 竜一, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 40回, p. 357-357, 2017/10
  • 食塩誘導性腎障害AT1RKOマウスにおけるLCZ696の薬効評価 腎臓線維化と糸球体保護作用を有する, 大津 礼,谷山 義明,眞田 文博,村津 淳,楽木 宏実,森下 竜一, 日本循環制御医学会総会プログラム・抄録集, 日本循環制御医学会, Vol. 38回, p. 92-92, 2017/06
  • 食塩誘導性腎障害AT1RKOマウスにおけるLCZ696の薬効評価 腎臓線維化と糸球体保護作用を有する, 大津 礼,谷山 義明,眞田 文博,村津 淳,楽木 宏実,森下 竜一, Anti-aging Science, (株)メディカルレビュー社, Vol. 8, No. 1, p. 62-62, 2016/12
  • Hepatocyte growth factor gene therapy for cardiovascular disease, Vol. 80, No. 4, p. 292-295, 2016/10
  • 【今、着実に実り始めた遺伝子治療-最新研究と今後の展開】 (第6章)循環器疾患/感染症と遺伝子治療 心不全の遺伝子治療, 谷山 義明,眞田 文博,村津 淳,楽木 宏実,森下 竜一, 遺伝子医学MOOK, (株)メディカルドゥ, No. 30, p. 266-269, 2016/06
  • PDE3 Inhibitor, Cilostazol, Ameliorates Ischemic Hindlimb Through cAMP and PPAR gamma Activation, Fumihiro Sanada,Yoshiaki Taniyama,Jyun Muratsu,Yuka Ikeda-Iwabu,Rei Otsu,Hiromi Rakugi,Ryuichi Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 132, 2015/11
  • LPS誘導疾患へのHGFを介した抗炎症作用の解明, 村津 淳,谷山 義明,清水 一賢,眞田 文博,池田 裕香,部,大津 礼,柴田 佳那,ブルーレー・メイ,加和子,楽木 宏実,森下 竜一, Anti-aging Science, (株)メディカルレビュー社, Vol. 7, No. 3, p. 199-199, 2015/11
  • アンジオテンシンII受容体拮抗薬のintegrinシグナル抑制作用によるLipoprotein(a)誘導動脈硬化に対する作用の解析, 村津 淳,谷山 義明,岩林 正明,眞田 文博,池田 裕香,部,大津 礼,柴田 佳那,ブルーレー・メイ,加和子,楽木 宏実,森下 竜一, Anti-aging Science, (株)メディカルレビュー社, Vol. 7, No. 3, p. 199-199, 2015/11
  • Lipoprotein(a)誘導動脈硬化に対するアンジオテンシンII受容体拮抗薬のintegrinシグナル抑制を介した抗動脈硬化作用の解析, 村津 淳,谷山 義明,岩林 正明,眞田 文博,池田 裕香,部,大津 礼,柴田 佳那,ブルーレイ・メイ,加和子,楽木 宏実,森下 竜一, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 38回, p. 363-363, 2015/10
  • マクロファージと脂肪細胞における炎症増悪をHGFが抑制する(Vicious Cycle of Inflammation via Humoral Factorin Macrophages and Adipocytes is Inhibited by HGF), 大津 礼,谷山 義明,楠 博,眞田 文博,村津 淳,森下 竜一,楽木 宏実, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 38回, p. 365-365, 2015/10
  • 知識と実行は素晴らしい結果と尊敬すべき記述を生む KEYWORD AgingとマイクロRNA : マイクロRNAは哺乳類のagingの過程に影響を与えている可能性がある, 谷山 義明,東 純哉,眞田 文博, Cardio-lipidology : 脂質代謝から考える心血管系, メディカルレビュー社, Vol. 9, No. 1, p. 46-49, 2015/06
  • Clonal C-kit-Positive Bone Marrow Cells and Cardiomyogenesis, Fumihiro Sanada,Junghyun Kim,Anna Czarna,Sergio Signore,Andrea Sorrentino,Chiara Mangiaracina,Ramaswamy Kannappan,Polina Goihberg,Marcello Rota,Toru Hosoda,Jan Kajstura,Piero Anversa,Annarosa Leri, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 128, No. 22, 2013/11
  • p53 Activity Controls Growth and Survival of Cardiac Stem Cells, Ramaswamy Kannappan,Giorgia Palano,Polina Goichberg,Fumihiro Sanada,Sergio Signore,Junghyun Kim,Laura Graciotti,Marcello Rota,Jan Kajstura,Piero Anversa,Annarosa Leri, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 128, No. 22, 2013/11
  • Transdifferentiation of Bone Marrow Cells and Cardiomyogenesis in the Infarcted Heart, Fumihiro Sanada,Junghyun Kim,Anna Czarna,Sergi Signore,Andrea Sorrentino,Chiara Mangiaracina,Antonio Cannata,Kazuya Isobe,Ramaswamy Kannappan,Maria Cimini,Alex Matsuda,Barbara Ogorek,Giorgia Palano,Maria V. Caballero,Manila Candiracci,Fiorenza Valeriani,Laura Graciotti,Polina Goihberg,Marcello Rota,Toru Hosoda,Jan Kajstura,Piero Anversa,Annarosa Leri, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 128, No. 22, 2013/11
  • Bone Marrow Cells Form New Cardiomyocytes in the Infarcted Myocardium, Fumihiro Sanada,Junghyung Kim,Anna Czarna,Sergio Signore,Andrea Sorrentino,Chiara Mangiaracina,Ramaswamy Kannappan,Kazuya Isobe,Polina Goichberg,Marcello Rota,Toru Hosoda,Jan Kajstura,Piero Anversa,Annarosa Leri, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 113, No. 4, 2013/08
  • Telomeric Shortening Induces a Senescent Cardiomyopathy that is Independent from Chronological age, Junghyun Kim,Fumihiro Sanada,Maria Cimini,Christian Arranto,Polina Goihberg,Toru Hosoda,Marcello Rota,Jan Kajstura,Piero Anversa,Annarosa Leri, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 111, No. 12, p. E381-E381, 2012/12
  • Clonal Analysis of Hematopoietic Stem Cell Transdifferentiation in the Regenerated Myocardium, Fumihiro Sanada,Kim Junghyun,Sergio Sinore,Kazuya Isobe,Joao Ferreira-Martins,Christian Arranto,Ramaswamy Kannapan,Maria Cimini,Alex Matsuda,Donato Cappetta,Ada Pesapane,Mario Ricciardi,Giorgia Palano,Polina Goihberg,Marcello Rota,Toru Hosoda,Jan Kajstura,Piero Anversa,Annarosa Leri, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 126, No. 21, 2012/11
  • Protection From Obesity and Systemic Insulin Resistance by Hepatocyte Growth Factor in Mice, Masaaki Iwabayashi,Yoshiaki Taniyama,Junya Azuma,Kazuma Iekushi,Fumihiro Sanada,Amarnath Chatterjee,Hiromi Rakugi,Ryuichi Mirishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 126, No. 21, 2012/11
  • Cardiac Stem Cell Function is Regulated by Hypoxic and Normoxic Niches within the Myocardium, Fumihiro Sanada,Junghyun Kim,Sergio Signore,Annarosa Leri, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 126, No. 21, 2012/11
  • Senescent Cardiomyocytes Modulate the Function of Cardiac Stem Cells in the Niches of the Old Heart, Junghyun Kim,Hanqiao Zheng,Donato Cappetta,Fumihiro Sanada,Christian Arranto,Narasimman Gurusamy,Polina Goihberg,Toru Hosoda,Marcello Rota,Jan Kajstura,Piero Anversa,Annarosa Leri, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 126, No. 21, 2012/11
  • Hypoxia Preserves the Quiescent Lineage Negative Phenotype of Cardiac Stem Cells Within the Niche, Fumihiro Sanada,Emily Mangano,Junghyung Kim,Christian Arranto,Joao Ferreira-Martins,Sergio Signore,Claudia Fiorini,Noriko Ide-Iwata,Ada Pesapane,Mario Ricciardi,Hanqiao Zheng,Narasimman Gurusamy,Ewa Wybieralska,Virginia Caballero,Maria Cimini,Polina Goichberg,Marcello Rota,Toru Hosoda,Jan Kajstura,Piero Anversa,Annarosa Leri, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 111, No. 4, 2012/08
  • Inositol Triphosphate Receptor Activation Alters the Electrical Properties of Human Ventricular Myocytes, Sergio Signore,Joao Ferreira-Martins,Kazuya Isobe,Ramaswamy Kannappan,Andrea Sorrentino,Mehrdad Shafaie,Elisabeth Steadman,Polina Goihberg,Christian Arranto,Fumihiro Sanada,Fabio Del Ben,Donato Cappetta,Ewa Wybieralska,Barbara Ogorek,Federica Del Monte,David A. D. Alessandro,Robert E. Michler,Marcello Rota, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 111, No. 4, 2012/08
  • Dysfunctional Cardiac Stem Cell Niches Condition the Aging of the Heart, Fumihiro Sanada,Hanqiao Zheng,Donato Cappetta,Emily Mangano,Junghyun Kim,Christian Arranto,Noriko Ide-Iwata,Ada Pesapane,Mario Ricciardi,Narasimman Gurusamy,Polina Goichberg,Marcello Rota,Toru Hosoda,Jan Kajstura,Piero Anversa,Annarosa Leri, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 111, No. 4, 2012/08
  • Hypoxia Preserves the Quiescent Lineage Negative Phenotype of Cardiac Stem Cells Within the Niche, Fumihiro Sanada,Emily Mangano,Junghyung Kim,Christian Arranto,Mehrdad Shafaie,Joao Ferreira-Martins,Sergio Signore,Claudia Fiorini,Noriko Ide-Iwata,Ada Pesapane,Mario Ricciardi,Barbara Ogorek,Hanqiao Zheng,Narasimman Gurusamy,Polina Goihberg,Marcello Rota,Toru Hosoda,Jan Kajstura,Piero Anversa,Annarosa Leri, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 109, No. 12, p. E57-E57, 2011/12
  • Role of Serotonin in Angiogenesis: Induction of Angiogenesis by Sarpogrelate via Endothelial 5-HT1B/Akt/eNOS Pathway in Diabetic Mice, Masaaki Iwabayashi,Yoshiaki Taniyama,Fumihiro Sanada,Junya Azuma,Kazuma Iekushi,Hiroshi Kusunoki,Amarnath Chatterjee,Keita Okayama,Hiromi Rakugi,Ryuichi Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 124, No. 21, 2011/11
  • Selective Blockade of Periostin 1 Decreased Infarct Size and Preserved Cardiac Performance in Rat Acute Myocardial Infarction, Keita Okayama,Yoshiaki Taniyama,Naruto Katsuragi,Junya Azuma,Kazuma Iekushi,Fumihiro Sanada,Nobutaka Koibuchi,Hiroshi Kusunoki,Masaaki Iwabayashi,Ryuichi Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 124, No. 21, 2011/11
  • HGF as Angiogenic Factor and Therapeutic Approach, Yoshiaki Taniyama,Yasushi Takeya,Junya Azuma,Kazuma Iekushi,Fumihiro Sanada,Hiroshi Kusunoki,Keita Okayama,Nobutaka Koibuchi,Hiromi Rakugi,Ryuichi Morishita, CURRENT SIGNAL TRANSDUCTION THERAPY, BENTHAM SCIENCE PUBL LTD, Vol. 6, No. 2, p. 221-227, 2011/05
  • PREVENTION OF END MT AND MYOFIBROBLAST PROLIFERATION AS A THERAPEUTIC TARGET FOR CARDIAC FIBROSIS, Keita Okayama,Yoshiaki Taniyama,Norio Dosaka,Junya Azuma,Fumihiro Sanada,Hiroshi Kusunoki,Masaaki Iwabayashi,Hiromi Rakugi,Ryuichi Morishita, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, Vol. 57, No. 14, p. E290-E290, 2011/04
  • DOCKING PROTEIN GAB1 IS ESSENTIAL FOR HGF-DEPENDENT ENDOTHELIAL SIGNALING AND ANGIOGENESIS AFTER HINDLIMB ISCHEMIA, Yoshikazu Nakaoka,Wataru Shioyama,Kaori Higuchi,Yo Arita,Fumihiro Sanada,Yoshiaki Taniyama,Ryuichi Morishita,Tadashi Kuroda,Yasushi Fujio,Keiko Yamauchi-Takihara,Naoki Mochizuki,Issei Komuro, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1050-1051, 2010/12
  • NEUTRALIZED ANTIBODY AGAINST PERIOSTIN 1 IMPROVED CARDIAC DYSFUNCTION IN RAT ACUTE MYOCARDIAL INFARCTION MODEL: PERIOSTIN-1 AS A NOVEL THERAPEUTIC TARGET FOR HEART FAILURE, Yoshiaki Taniyama,Junya Azuma,Kazuma Iekushi,Fumihiro Sanada,Norio Dosaka,Hiroshi Kusunoki,Keita Okayama,Hiromi Rakugi,Ryuichi Morishita, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1050-1050, 2010/12
  • HEPATOCYTE GROWTH FACTOR ATTENUATES TGF-beta 1 ANGIOTENSIN II CROSSTALK BY DOWN REGULATION OF ANGIOTENSIN II TYPE 1 RECEPTOR THROUGH PTEN UPREGULATION, Hiroshi Kusunoki,Yoshiaki Taniyama,Kazuma Iekushi,Junya Azuma,Fumihiro Sanada,Norio Dosaka,Toyohiko Yokoi,Nobutaka Koibuchi,Mariko Kyutoku,Hiromi Rakugi,Ryuichi Morishita, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1026-1026, 2010/12
  • NEGATIVE ACTION OF HGF/c-MET SYSTEM ON ANGIOTENSIN II SIGNALING VIA LIGAND-DEPENDENT EGF RECEPTOR DEGRADATION MECHANISM IN VSMC, Fumihiro Sanada,Yoshiaki Taniyama,Kazuma Iekushi,Junya Azuma,Norio Dosaka,Kenichi Shimizu,Hiroshi Kusunoki,Nobutaka Koibuchi,Ryuichi Morishita, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1026-1027, 2010/12
  • The Protective effect of Hepatocyte Growth Factor on LPS-induced Inflammation via Epithelial Growth Factor Degradation, Masaaki Iwabayashi,Yoshiaki Taniyama,Kazutaka Shimizu,Fumihiro Sanada,Kazuma Iekushi,Keita Okayama,Hiroshi Kusunoki,Mariko Kyutoku,Amarnath Chatterjee,Junya Azuma,Ryuichi Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 122, No. 21, 2010/11
  • Protective Effects of Hepatocyte Growth Factor on LPS-Induced Inflammation via Epithelial Growth Factor Receptor Degradation, Yoshiaki Taniyama,Kenichi Shimizu,Fumihiro Sanada,Kyutoku Mariko,Junya Azuma,Kazuma Iekushi,Keita Okayama,Hiroshi Kusunoki,Masaaki Iwabayashi,Hiromi Rakugi,Ryuichi Morishita, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 30, No. 11, p. E217-E217, 2010/11
  • Hepatocyte Growth Factor Reduces Cardiac Fibrosis Through Inhibiting Endothelial-Mesenchymal Transition and Proliferation of Myofibroblast, Keita Okayama,Yoshiaki Taniyama,Norio Dosaka,Junya Azuma,Kazuma Iekushi,Fumihiro Sanada,Hiroshi Kusunoki,Hiromi Rakugi,Ryuichi Morishita, JOURNAL OF CARDIAC FAILURE, CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS, Vol. 16, No. 9, p. S165-S165, 2010/09
  • Gene therapy for vascular disease, Japanese journal of clinical medicine, Vol. 68, p. 641-645, 2010/08
  • Therapeutic angiogenesis for diabetes mellitus related ischemic disease, Japanese journal of clinical medicine, Vol. 68, No. 5, p. 949-952, 2010/05
  • Hepatocyte Growth Factor Attenuates Renal Fibrosis Through Myofibroblasts Anoikis Induced by FAK/MMP Activaton, Kazuma Iekushi,Yoshiaki Taniyama,Junya Azuma,Fumihiro Sanada,Norio Dosaka,Keita Okayama,Hiroshi Kusunoki,Toyohiko Yokoi,Hiromi Rakugi,Ryuichi Moroshita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 120, No. 18, p. S1054-S1055, 2009/11
  • URSODEOXYCHOLIC ACID SUPPRESSES ENDOTHELIAL CELL PLASMINONEN ACTIVATOR INHIBITOR-1 EXPRESSION INDUCED BY HIGH GLUCOSE DEPEND ON TRANSFORMING GROWTH FACTOR SIGNALING, T. Yokoi,K. Iekushi,M. Yoshika,F. Sanada,M. Masuda,Y. Komiyama,Y. Taniyama,H. Masaki,R. Morishita,H. Takahashi, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 27, p. S395-S395, 2009/06
  • Ursodeoxycholic Acid Suppresses Endothelial Cell Plasminonen Activator Inhibitor-1 Expression Induced by, High Glucose Depends on Transforming Growth Factor Signaling, Toyohiko Yokoi,Fumihiro Sanada,Yoshiharu Wada,Masamichi Yo-Shika,Kazuma Iekushi,Midori Masuda,Yutaka Komiyama,Yoshiaki Taniyama,Hiroya Maski,Ryuichi Morishita,Hiroyuki Koshiyama,Hakuo Takahashi, DIABETES, AMER DIABETES ASSOC, Vol. 58, p. A164-A164, 2009/06
  • URSODEOXYCHOLIC ACID INHIBITS ENDOTHELIAL CELL PLASMINONEN ACTIVATOR INHIBITOR-1 EXPRESSION INDUCED BY HIGH GLUCOSE, T. Yokoi,F. Sanada,M. Yoshika,K. Iekushi,M. Masuda,Y. Komiyama,Y. Taniyama,H. Masaki,R. Morishita,H. Takahashi, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 10, No. 2, 2009/06
  • DPJ-013 Hepatocyte Growth Factor Attenuates TGF-β1 Angiotensin II Crosstalk by Down Regulation of Angiotensin II Type 1 Receptor through PTEN/Akt Pathway(DPJ03,Kidney/Renal Circulation/CKD (H),Digital Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society), Iekushi Kazuma,Taniyama Yoshiaki,azuma jyunya,Sanada Fumihiro,Dohsaka Norio,Yokoi Toyohiko,Kusunoki Hiroshi,Koibuchi Nobutaka,Rakugi Hiromi,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 73, p. 379-379, 2009/03/01
  • PJ-740 Hepatocyte Growth Factor (HGF), but not Vascular Endothelial Growth Factor (VEGF), Attenuated Ang II-induced EC Senescence by Inhibiting PIP3/rac1 Activity(PJ124,Peripheral Cirulation/Vascular Disease (Therapy) 4 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society), Sanada Fumihiro,Taniyama Yoshiaki,Iekushi Kazuma,Dohsaka Norio,Azuma Junya,Kusunoki Hiroshi,Koibuchi Nobutaka,Aizawa Yoshifusa,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 73, p. 732-732, 2009/03/01
  • OJ-060 Hepatocyte Growth Factor Attenuate Ang II-induced Inflammation and Proliferation of Smooth Muscle Cell through EGF Receptor Degradation(OJ10,Atherosclerosis, Basic (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society), Sanada Fumihiro,Taniyama Yoshiaki,Iekushi Kazuma,Dohsaka Norio,Azuma Junnya,Kusunoki Hiroshi,Koibuchi Nobutaka,Aizawa Yoshifusa,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 73, p. 300-300, 2009/03/01
  • FRS-003 Docking Protein Gab1 is Essential for HGF-dependent Endothelial Signaling and Angiogenesis after Hindlimb Ischemia(FRS1,New Molecules for Cardiovascular Regulation (M),Featured Research Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society), Shioyama Wataru,Higuchi Kaori,Hiramoto Yoshimune,Arita Yo,Kuroda Tadashi,Fujio Yasushi,Sanada Fumihiro,Taniyama Yoshiaki,Morishita Ryuichi,Takihara Keiko,Hirano Toshio,Hori Masatsugu,Mochizuki Naoki,Nakaoka Yoshikazu, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 73, p. 134-134, 2009/03/01
  • Hapatocyte Growth Factor Attenuates Angiotensin II Induced Renal Fibrosis through TGF-beta 1 Suppression by Anoikis of Myofibroblasts, Kazuma Iekushi,Yoshiaki Taniyama,Junya Azuma,Fumihiro Sanada,Norio Dosaka,Hiroshi Kusunoki,Nobutaka Koibuchi,Hiromi Rakugi,Ryulchl Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 118, No. 18, p. S337-S337, 2008/10
  • Scaffolding Docking Protein Gab1 Is Essential for HGF-Mediated Endothelial Signaling and Angiogenesis after Hind-Limb Ischemia, Yoshimune Hiramoto,Wataru Shioyama,Kaori Higuchi,Kitaro Okamoto,Yo Arita,Tadashi Kuroda,Fumihiro Sanada,Yoshiaki Taniyama,Ryuichi Morishita,Keigo Nishida,Yasushi Fujio,Keiko Yamauchi-Takihara,Toshio Hirano,Naoki Mochizuki,Yoshikazu Nakaoka, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 118, No. 18, p. S549-S550, 2008/10
  • Hepatocyte growth factor (HGF), but not vascular endothelial growth factor (VEGF), attenuated Ang II-induced senescence in EPC through anti-oxidative stress effect by inhibiting rac1 activation, F. Sanada,Y. Taniyama,K. Iekushi,N. Dousaka,T. Yokoi,R. Morishita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 26, p. S320-S320, 2008/06
  • Hepatocyte growth factor attenuates Angiotensin II induced renal fibrosis through TGF-beta suppression toy anoikis of myofibroblasts, K. Iekushi,Y. Taniyama,F. Sanada,N. Dosaka,R. Morishita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 26, p. S515-S515, 2008/06
  • PJ-345 Hepatocyte Growth Factor Attenuates Angiotensin II Induced Renal Fibrosis through TGF-B Suppression by Anoikis of Myofibroblasts(Kidney/Renal circulation(06)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society), Iekushi Kazuma,Taniyama Yoshiaki,Dohsaka Norio,Sanada Fumihiro,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 72, p. 598-598, 2008/03/01
  • OJ-125 HGF,but not VEGF, Attenuated Angiotensin II-induced Senescence in EPC through Anti-Oxidative Stress Effect by Inhibiting Rac1 Activation.(Regeneration(angiogenesis / myocardial regeneration)(02)(M),Oral Presentation (Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society), Sanada Fumihiro,Taniyama Yoshiaki,Iekushi Kazuma,Dohsaka Norio,Yokoi Toyohiko,Aizawa Yoshifusa,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 72, p. 319-319, 2008/03/01
  • PJ-145 Periostin as a Novel Therapeutic Target for Heart Failure(Acute coronary syndrome, basic/clinical-7, The 71st Annual Scientific Meeting of the Japanese Circulation Society), Taniyama Yoshiaki,Katsuragi Naruto,Azuma Junya,Iekushi Kazuma,Dosaka Yoshio,Sanada Fumihiro,Koibuchi Nobutaka,Nagao Kaori,Ogihara Toshio,Morisihta Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 71, p. 508-508, 2007/03/01
  • PJ-686 Hepatocyte Growth Factor Can Attenuate Senescense of EPC through Anti-oxidative Stress Effect(Peripheral circulation/Vascular disease-6, The 71st Annual Scientific Meeting of the Japanese Circulation Society), Sanada Fumihiro,Taniyama Yoshiaki,Azuma Junnya,Iekushi Kazuma,Dousaka Yoshio,Yokoi Toyohiko,AIzawa Yoshifusa,Morishita Ryuuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 71, p. 643-643, 2007/03/01